About this episode

Colin Murdoch and Ron Alfa discuss the future of cancer care and the impact of AI on diagnostics and precision medicine.

Colin Murdoch, president of Isomorphic Labs and Ron Alfa, CEO and co-founder of Noetik, join Washington Post Live to discuss the future of diagnostics, precision medicine, the Trump administration's recent cuts to cancer research and the evolution of cancer care. Conversation recorded on Wednesday, September 17, 2025. Program sponsored by Pfizer

People in this episode

Host: Washington Post Live

Guests: Colin Murdoch, Ron Alfa

Topics covered

• AI in healthcare
• cancer care
• precision medicine
• diagnostics
• cancer research
• Trump administration

Keywords

• AI
• cancer care
• diagnostics
• precision medicine
• cancer research
• Trump administration
• healthcare

Sponsors

Pfizer

Mentioned in this episode

Organizations: Isomorphic Labs, Noetik

More episodes of Washington Post Live

• The future of sports, powered by AI · December 19, 2025 · 0 min
• The next chapter in cancer treatment · December 12, 2025 · 0 min
• Conversations from the Global Women's Summit · December 5, 2025 · 1h 7m
• Conversations from the Global Women's Summit · November 28, 2025 · 1h 4m
• Conversations from the Global Women's Summit · November 21, 2025 · 1h 11m
• The revolution in cancer care · October 10, 2025 · 47 min

Explore listener stats, chart rankings, contacts and more on the Washington Post Live podcast page.